Abstract
Health disparities between men and women have become apparent in recent years in many fields, including the transplant setting. In this chapter, we address gender inequities in liver transplantation, including the type of liver diseases that leads to the need of transplantation, the referral pattern to transplant centers, access to waiting lists, and transplantation itself as well as posttransplant outcome. An analysis and literature search that integrates sociocultural, biological, and physiopathological perspectives is included in each of these different steps. Furthermore, recommendations regarding specific strategies that can be developed to reduce gender disparities in liver transplant care are also suggested. Particularly, changes in the liver allocation system and a consideration for a greater use of live donors and split livers are potential means to improving access to liver transplantation for women.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gahagan J, Gray K, Whynacht A. Sex and gender matter in health research: addressing health inequities in health research reporting. Int J Equity Health. 2015;14:12.
Miller VM. In pursuit of scientific excellence: sex matters. Am J Physiol Lung Cell Mol Physiol. 2012;302:L801–2.
Melk A, Babitsch B, Borchert-Mörlins B, et al. Equally interchangeable? - how sex and gender affect transplantation. Transplantation. 2019;103(6):1094–110.
Durazzo M, Belci P, Collo A, et al. Gender specific medicine in liver diseases: a point of view. World J Gastroenterol. 2014;20:2127–35.
Nagoshi S. Sex- or gender-specific medicine in hepatology. Hepatol Res. 2008;38:219–24.
Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci. 1975;252:85–105.
JK N, S O, Bergmann OM, et al. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease. Scand J Gastroenterol. 2017;52:762–7.
Bhala N, Cézard G, Ward HJ, et al. Ethnic variations in liver- and alcohol-related disease hospitalisations and mortality: the Scottish Health and Ethnicity Linkage Study. Alcohol Alcohol. 2016;51:593–601.
Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322:95–9.
Non-Alcoholic Fatty Liver Disease Study Group, Lonardo A, Bellentani S, et al. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups. Dig Liver Dis. 2015;47:997–1006.
Fadini GP, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol. 2008;28:997–1004.
Carulli L, Lonardo A, Lombardini S, et al. Gender, fatty liver and GGT. Hepatology. 2006;44:278–9.
Turola E, Petta S, Vanni E, et al. Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. Dis Model Mech. 2015;8:1037–46.
Bruno S, Maisonneuve P, Castellana P, et al. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ. 2005;330:932.
Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.
Wang Z, Xu M, Hu Z, et al. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China. Eur J Gastroenterol Hepatol. 2014;26:1015–21.
Klair JS, Yang JD, Abdelmalek MF. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology. 2016;64:85–91.
Kurt Z, Barrere-Cain R, LaGuardia J, et al. Tissue-specific pathways and networks underlying sexual dimorphism in nonalcoholic fatty liver disease. Biol Sex Differ. 2018;9:46.
Amadori A, Zamarchi R, De Silvestro G, et al. Genetic control of the CD4/CD8 cell ratio in humans. Nat Med. 1995;1:1279–83.
Nalbandian G, Van de Water J, Gish R, et al. Is there a serological difference between men and women with primary biliary cirrhosis? Am J Gastroenterol. 1999;94:2482–6.
Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut. 1986;27:1373–6.
Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol. 2002;97:3160–5.
Villa E, Vukotic R, Cammà C, et al. Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS One. 2012;7(9):e44624.
Grebely J, Bryant J, Hull P, et al. Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia. J Viral Hepat. 2011;18:e104–16.
Agostini H, Castera L, Melin P, et al. HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naive patients managed in the French health care system. Gastroenterol Clin Biol. 2007;31:1074–80.
Charlebois A, Lee L, Cooper E, et al. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients. J Viral Hepat. 2012;19:836–42.
Kanwal F, Kramer JR, El-Serag HB, et al. Race and gender differences in the use of direct acting antiviral agents for hepatitis C virus. Clin Infect Dis. 2016;63:291–9.
Kramer JR, El-Serag H, Taylor TJ, et al. HCV-related complications are increasing in women veterans: a national cohort study. J Viral Hepat. 2017;24:955–65.
Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol. 2001;2:349–51.
Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–54.
Mennecozzi M, Landesmann B, Palosaari T, et al. Sex differences in liver toxicity—do female and male human primary hepatocytes react differently to toxicants in vitro? PlosOne. 2015;10(4):e0122786.
Schaubel DE, Stewart DE, Morrison HI, et al. Sex inequality in kidney transplantation rates. Arch Intern Med. 2000;160:2349–54.
Bloembergen WE, Mauger EA, Wolfe RA, et al. Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis. 1997;30:733–8.
Thamer M, Hwang W, Fink NE, et al. U.S. nephrologists’ attitudes towards renal transplantation: results from a national survey. Transplantation. 2001;71:281–8.
Kucirka LM, Grams ME, Balhara KS, et al. Disparities in provision of transplant information affect access to kidney transplantation. Am J Transplant. 2012;12:351–7.
Bryce CL, Chang C, Angus DC, et al. The effect of race, sex, and insurance status on time-to-listing decisions for liver transplantation. J Tranplant. 2010;2010:467976.
Mathur AK, Ashby VB, Fuller DS, et al. Variation in access to the liver transplant waiting list in the United States. Transplantation. 2014;98:94–9.
Oloruntoba O, Moylan CA. Gender-based disparities in access to and outcomes of liver transplantation. World J Hepatol. 2015 March 27;7(3):460–7.
Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–8.
Mathur AK, Schaubel DE, Gong Q, et al. Sex-based disparities in liver transplant rates in the United States. Am J Transplant. 2011;11:1435–43.
Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias. Am J Transplant. 2007;7:685–92.
Meyers RP, Shaheen AA, Aspinall AI, et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462–70.
Lai JC, Terrault NA, Vittinghoff E, et al. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010;10:2658–64.
Nephew LD, Goldberg DS, Lewis JD, et al. Exception points and body size contribute to gender disparity in liver transplantation. Clin Gastroenterol Hepatol. 2017;15:1286–93.
Mindikoglu AL, Emre SH, Magder LS. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl. 2013;19:89–95.
Cullaro G, Sarkar M, Lai JC. Sex-based disparities in delisting for being “too sick” for liver transplantation. Am J Transplant. 2018;18:1214–9.
Allen AM, Heimbach JK, Larson JJ, et al. Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation. Transplantation. 2018;102:1710–6.
Bruns H, Lozanovski VJ, Schultze D, et al. Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis. PLoS One. 2014;9(6):e98782.
Thuluvath PJ, Guidinger MK, Fung JJ, et al. Liver transplantation in the United States, 1999-2008. Am J Transplant. 2010;10:1003–19.
Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015;62:946–55.
Mathur AK, Schaubel DE, Zhang H, al e. Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex. Transplantation. 2014;97:862–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Serrano, T., Berenguer, M. (2020). Gender Disparities in Liver Transplantation. In: Rahimi, R. (eds) The Critically Ill Cirrhotic Patient. Springer, Cham. https://doi.org/10.1007/978-3-030-24490-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-24490-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24489-7
Online ISBN: 978-3-030-24490-3
eBook Packages: MedicineMedicine (R0)